维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="Ambinder"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide显示文摘	Leo Luznik Paul V. O'Donnell Heather J. Symons Allen R. Chen M. Susan Leffell Marianna Zahurak Ted A. Gooley Steve Piantadosi Michele Kaup Richard F. Ambinder Carol Ann Huff William Matsui Javier Bola?os-Meade Ivan Borrello Jonathan D. Powell Elizabeth Ha	2008	Biology of Blood and Marrow Transplantation2008，，6：	4
2	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
3	Cancer Biomarkersin HIV patients显示文摘	Ambinder RF Bhatia K Martinez-Maza O	2010	Curropin HIV AIDS2010，5，6：	1
4	Gemcitabine as first line therapy in patients with metastatic breast cancer a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
5	Cancer biomarkers in HIV patients显示文摘	Richard F Ambinder Kishor Bhatia Otoniel Martinez-Maza Ronald Mitsuyasu	2010	Current Opinion in HIV and AIDS2010，，6：	1
6	Cancer Biomarkers in HIV patients显示文摘	Ambinder RF Bhatia K Martinez-Maza O		0，，：	1
7	Gemeitabine as first line therapy in patients with metastaticbreast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel C L Ambinder R	2002	Oncology2002，62，1：	1
8	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a Phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
9	Gemeitabine as firest-line therapy in patient with metastatic breast cancer: aphase Ⅱ trial显示文摘	Blaekstein M Vogel C L Ambinder R	2002	Oncology2002，62，：	1
10	Gemcitabine as first -line therapy in patients with metastatic breast cancer ;a phase Ⅱ trial显示文摘	VOGEL C L AMBINDER R	2002	Oncology2002，62，1：	1
11	Gemcitabine as firsfline thempy in patients with metastatic breast cancer:a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
12	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blaekstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
13	Gemcitabine as firstline therapy in patients with metastatic breast cancer: aphase II trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
14	Gemcetabine as first-line therapy in patients with metastatic breast cancer:a phase Ⅱ trail显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
15	Gemcitabine as first line therapy in patientwith metastatic breast cancer: a phase Ⅱ trial 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，：	1
16	Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
17	Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma:AIDS-malignancies consortium trial 010显示文摘	Kaplan LD Lee JY Ambinder RF	2005	Blood2005，106，5：	1
18	Gemcitabine as first line therapy in patient with metastatic breast cancer,a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1
19	Gemcitabin as firstline therapy in patients with metastatic breast cancer: a phase Ⅱ trial显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，52，1：	1
20	Gemcitabine as firs-line therapy in patinets with metastatic breast cancer a phas II trail 显示文摘	Blackstein M Vogel CL Ambinder R	2002	Oncology2002，62，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示